The DOI matches its Crossref record; 97 of the 98 references it cites were found in a registry or an index.
Morbidity in Turner Syndrome
Abstract
Turner syndrome afflicts approximately 50 per 100,000 females and is characterized by retarded growth, gonadal dysgenesis, and infertility. Much attention has been focused on growth and growth promoting therapies, while less is known about the natural course of the syndrome, especially in adulthood. We undertook this study to assess the incidence of diseases relevant in the study of Turner syndrome. The study period was from January 1, 1984 to December 31, 1993, and the study base was all women living in Denmark during the study period. We used data from the Danish Cytogenetic Central Register and the Danish National Registry of Patients to assess morbidity. This study supports several earlier studies reporting increased morbidity and confirms results of a recent study on cancer in Turner syndrome. Women with Turner syndrome seem to have an increased incidence of fractures, osteoporotic fractures in adulthood, and non-osteoporotic fractures in childhood. Furthermore, diabetes mellitus, both NIDDM and IDDM, was found with a markedly increased incidence in Turner syndrome, as well as ischemic heart disease, hypertension, and stroke. The risk of cancer, except cancer of the large bowel, does not seem to be elevated in Turner syndrome. Our data suggest that patients with Turner syndrome are extraordinarily prone to abnormalities constituting the metabolic syndrome (e.g., hypertension, dyslipidaemia, NIDDM, obesity, hyperinsulinemia and hyperuricemia). The present data may help to explain the decreased life span found in patients with Turner syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the presence of LFA, the risk of cirrhosis among TS is six times higher than in the general population.344,716”
From Clinical practice guidelines for the care of girls and women with Turner syndrome. (2024) · cites this paper as [716]
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Statistical Methods in Cancer Research
Breslow, N. E. (1980) · Cited by 7,332
Banting lecture 1988. Role of insulin resistance in human disease.
Reaven, G. (1988) · Diabetes · doi:10.2337/diabetes.37.12.1595 · Cited by 3,801
Williams Textbook of Endocrinology
Melmed, S., & Polonsky, K. S. (2016) · Elsevier eBooks · doi:10.1016/c2013-0-15980-6 · Cited by 3,715
Statistical Methods in Cancer Research. Volume II – The Design and Analysis of Cohort Studies
Juul, S. (1989) · Scandinavian Journal of Social Medicine · doi:10.1177/140349488901700214 · Cited by 3,602
Limitations of the Application of Fourfold Table Analysis to Hospital Data
Berkson, J. (1946) · Biometrics Bulletin · doi:10.2307/3002000 · Cited by 1,810
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz, G. A., Hankinson, S. E., Hunter, D. J., Willett, W. C., Manson, J. E., Stampfer, M. J., Hennekens, C., Rosner, B., & Speizer, F. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506153322401 · Cited by 1,487
The design and analysis of cohort studies
Breslow, N. E., & Day, N. E. (1987) · International Agency for Research on Cancer eBooks · Cited by 1,312
A SYNDROME OF INFANTILISM, CONGENITAL WEBBED NECK, AND CUBITUS VALGUS1
TURNER, H. H. (1938) · Endocrinology · doi:10.1210/endo-23-5-566 · Cited by 1,124
Williams Textbook of Endocrinology
Reutrakul, S. (2009) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000323673.44568.e8 · Cited by 710
Research works printed but not linked: 4
- Tamborlane, 1988, Insulin resistance and compensatory hyperinsulinaemia in Turner's syndrome, Diabetologia, 31, 548A
- Emans, 1990, Estrogen deficiency in adolescents and young adults, Obstet Gynecol, 76, 585
- Cheng, 1993, Turner's syndrome associated with sigmoid polyp and colon cancer, J Formos Med Assoc, 92, 580
- Binder, 1995, Nested polymerase chain reaction study of 53 cases with Turner's syndrome, J Clin Endocrinol Metab, 80, 3532, 10.1210/jc.80.12.3532 · DOI
Cited by
Sorted by citations
The Danish National Patient Registry: a review of content, data quality, and research potential
Schmidt, M., Schmidt, S. A. J., Sandegaard, J. L., Ehrenstein, V., Pedersen, L. H., & Sørensen, H. T. (2015) · Clinical Epidemiology · doi:10.2147/clep.s91125 · Cited by 4,832
ESHRE Guideline: management of women with premature ovarian insufficiency
The ESHRE Guideline Group on POI, Webber, L. J., Davies, M. C., Anderson, R. A., Bartlett, J., Braat, D. D. M., Cartwright, B., Cífková, R., Keizer‐Schrama, S. D. M., Hogervorst, E., et al. (2016) · Human Reproduction · doi:10.1093/humrep/dew027 · Cited by 1,603
“All women diagnosed with Turner Syndrome should be evaluated by a cardiologist with expertise in congenital heart disease (Gravholt et al., 1998; Bondy, 2008; Sharma et al., 2009) C”
BackgroundInfluentialCost of Lost Productive Work Time Among US Workers With Depression
Stewart, W. F. (2003) · JAMA · doi:10.1001/jama.289.23.3135 · Cited by 1,421
Gravholt, C. H., Andersen, N. H., Conway, G. S., Dekkers, O. M., Geffner, M. E., Klein, K. O., Lin, A. E., Mauras, N., Quigley, C. A., Rubin, K., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0430 · Cited by 1,101
Self-citationCare of girls and women with Turner syndrome: a guideline of the Turner syndrome study group
Bondy, C. A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1374 · Cited by 1,005
“diabetes, and dyslipidemia, which are increased in TS (143).”
BackgroundSybert, V. P., & McCauley, E. (2004) · New England Journal of Medicine · doi:10.1056/nejmra030360 · Cited by 918
Prenatal and postnatal prevalence of Klinefelter syndrome: a national registry study
Bojesen, A., Juul, S., & Gravholt, C. H. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021491 · Cited by 894
“Reasons for performing prenatal examinations have been described earlier (18).”
BackgroundPrevalence, incidence, diagnostic delay, and mortality in Turner syndrome
Stochholm, K., Juul, S., Juel, K., Naeraa, R. W., & Højbjerg Gravholt, C. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0558 · Cited by 652
Puberty : ontogeny, neuroendocrinology, physiology, and disorders
Styne, D. M., Grumbach, M. M., Dennis, M., Styne, J., & Melvin, M. N. (1998) · Time to knit · doi:10.1016/b978-1-4160-2911-3.50026-1 · Cited by 546
Turner's Syndrome in Adulthood
Elsheikh, M., Dunger, D. B., Conway, G. S., & Wass, J. A. H. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.1.0457 · Cited by 395
“Congenital renal anomalies are approximately 9 times more common in females with TS compared with the general population (59).”
BackgroundInfluentialRecommendations for the Diagnosis and Management of Turner Syndrome
Saenger, P. H., Wikland, K. A., Conway, G. S., Davenport, M., Gravholt, C. H., Hintz, R. L., Hovatta, O., Hultcrantz, M., Landin‐Wilhelmsen, K., Lin, A. E., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7683 · Cited by 419
“Measurements of bone mineral density should therefore be performed at the initial visit in adults with TS and 3–5 yr later (59, 68).”
BackgroundMethodMortality in women with Turner syndrome in Great Britain: a national cohort study
Schoemaker, M. J., Swerdlow, A. J., Higgins, C. D., Wright, A. F., & Jacobs, P. A. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1049 · Cited by 360
Turner syndrome: mechanisms and management
Gravholt, C. H., Viuff, M. H., Brun, S., Stochholm, K., & Andersen, N. H. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0224-4 · Cited by 356
Ebeling, P. R., Nguyen, H. H., Aleksova, J., Vincent, A. J., Wong, P., & Milat, F. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab028 · Cited by 364
Sex Hormones and Sex Chromosomes Cause Sex Differences in the Development of Cardiovascular Diseases
Arnold, A. P., Cassis, L. A., Eghbali, M., Reue, K., & Sandberg, K. L. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.307301 · Cited by 339
“In contrast, women with monosomy X (Turner syndrome) have an atherogenic lipid profile (increased LDL cholesterol level and particle size)(100) and exhibit an increased risk for ischemic heart disease.(101) Most sex chromosome aneuploidy conditions (eg, XO and XXY) in humans, however, involve concomitant changes in go…”
Morbidity in Klinefelter Syndrome: A Danish Register Study Based on Hospital Discharge Diagnoses
Bojesen, A., Juul, S., Birkebæk, N., & Gravholt, C. H. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0697 · Cited by 329
“The reasons for performing karyotype examinations have been described previously (20).”
BackgroundClinical and epidemiological description of aortic dissection in Turner's syndrome
Gravholt, C. H., Landin‐Wilhelmsen, K., Stochholm, K., Hjerrild, B., Ledet, T., Djurhuus, C., Sylvén, L., Baandrup, U. T., Kristensen, B. Ø., & Christiansen, J. S. (2006) · Cardiology in the Young · doi:10.1017/s1047951106000928 · Cited by 264
Ranke, M. B., & Saenger, P. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05487-3 · Cited by 345
Gravholt, C. H., Fedder, J., Næraa, R. W., & Müller, J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.9.6800 · Cited by 256
“45,X/46,X,i(Xq); 46,X,i(Xq); 17 (15) 45,X/46,X,i(Xq)/47,X,i(Xq),i(Xq) etc. 45,X/46,X,del(X); 46,X,del(X) 8 ( 7 )”
BackgroundMethodInfluentialEpidemiological, endocrine and metabolic features in Turner syndrome
Gravholt, C. H. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1510657 · Cited by 249
Cardiovascular Health in Turner Syndrome: A Scientific Statement From the American Heart Association
Silberbach, M., Roos‐Hesselink, J. W., Andersen, N. H., Braverman, A. C., Brown, N. M., Collins, R. T., Backer, J. F. A. D., Eagle, K. A., Hiratzka, L. F., Johnson, W. H., et al. (2018) · Circulation Genomic and Precision Medicine · doi:10.1161/hcg.0000000000000048 · Cited by 250
Stroke in Women: Disparities and Outcomes
Persky, R., Turtzo, L. C., & McCullough, L. D. (2010) · Current Cardiology Reports · doi:10.1007/s11886-009-0080-2 · Cited by 224
“hypertension, and heart disease, even after they are supplemented with estrogen [20].”
BackgroundCardiovascular Phenotype in Turner Syndrome—Integrating Cardiology, Genetics, and Endocrinology
Mortensen, K. H., Andersen, N. H., & Gravholt, C. H. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1059 · Cited by 221
“pertension are substantial (3, 4), and there is an unfortu-”
BackgroundInfluentialClinical practice guidelines for the care of girls and women with Turner syndrome.
Gravholt, C. H., Andersen, N. H., Christin-Maitre, S., Davis, S. M., Duijnhouwer, A., Gawlik, A., Maciel-Guerra, A. T., Gutmark-Little, I., Fleischer, K., Hong, D., et al. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae050 · Cited by 224
Cancer incidence in women with Turner syndrome in Great Britain: a national cohort study
Schoemaker, M. J., Swerdlow, A. J., Higgins, C. D., Wright, A. F., & Jacobs, P. A. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70033-0 · Cited by 202
Sex Differences in Peripheral Artery Disease
Pabón, M. A., Cheng, S. C., Altin, S. E., Sethi, S. S., Nelson, M. D., Moreau, K. L., Hamburg, N. M., & Hess, C. N. (2022) · Circulation Research · doi:10.1161/circresaha.121.320702 · Cited by 206
Delayed diagnoses of Turner's syndrome: proposed guidelines for change
Sävendahl, L., & Davenport, M. L. (2000) · The Journal of Pediatrics · doi:10.1067/mpd.2000.107390 · Cited by 180
Berglund, A., Viuff, M. H., Skakkebaek, A. H., Chang, S., Stochholm, K., & Gravholt, C. H. (2019) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-018-0976-2 · Cited by 183
Increased Mortality in Klinefelter Syndrome
Bojesen, A., Juul, S., Birkebæk, N., & Gravholt, C. H. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0777 · Cited by 185
“The reasons for performing karyotype examinations have been described previously (15).”
BackgroundAutoimmune diseases in women with Turner's Syndrome
Jørgensen, K. T., Rostgaard, K., Bache, I., Biggar, R. J., Nielsen, N. M., Tommerup, N., & Frisch, M. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27270 · Cited by 176
Increased prevalence of autoimmunity in Turner syndrome – influence of age
Mortensen, K. H., Cleemann, L. H., Hjerrild, B., Nexø, E., Locht, H., Jeppesen, E. M., & Gravholt, C. H. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.03895.x · Cited by 170
Hypothyroidism is common in Turner syndrome: results of a five-year follow-up
El-Mansoury, M., Bryman, I., Berntorp, K., Hanson, C., Wilhelmsen, L., & Landin-Wilhelmsen, K. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1262 · Cited by 166
Energy metabolism and fertility—a balance preserved for female health
Torre, S. D., Benedusi, V., Fontana, R., & Maggi, A. C. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.203 · Cited by 162
Turner's syndrome and fertility: current status and possible putative prospects
Abir, R. (2001) · Human Reproduction Update · doi:10.1093/humupd/7.6.603 · Cited by 154
“Abnormal mesenteric bleeding is common, as is Crohn's disease, ulcerative colitis and various other metabolic disorders such as glucose intolerance with mild insulin resistance and obesity (Saenger, 1996; Gravholt et al., 1998).”
BackgroundInfluentialEstrogen replacement in Turner syndrome: literature review and practical considerations
Klein, K. O., Rosenfield, R. L., Santen, R. J., Gawlik, A. M., Backeljauw, P. F., Gravholt, C. H., Sas, T. C. J., & Mauras, N. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02183 · Cited by 151
“Glucose and insulin The risk of type 1 and type 2 diabetes mellitus is increased in patients with TS across all ages (68).”
BackgroundOstberg, J. E., Donald, A. E., Halcox, J., Storry, C., McCarthy, C., & Conway, G. S. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0677 · Cited by 149
Chevalier, N., Letur, H., Lelannou, D., Ohl, J., Cornet, D., Chalas-Boissonnas, C., Frydman, R., Catteau-Jonard, S., Greck-Chassain, T., Papaxanthos-Roche, A., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0925 · Cited by 142
Widespread DNA hypomethylation and differential gene expression in Turner syndrome
Trolle, C., Nielsen, M. M., Skakkebæk, A., Lamy, P., Vang, S., Hedegaard, J., Nordentoft, I., Ørntoft, T. F., Pedersen, J. S., & Gravholt, C. H. (2016) · Scientific Reports · doi:10.1038/srep34220 · Cited by 149
The changing face of Turner syndrome
Gravholt, C. H., Viuff, M., Just, J., Sandahl, K., Brun, S., van der Velden, J., Andersen, N. H., & Skakkebaek, A. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnac016 · Cited by 149
Reproductive Endocrinology of Nonalcoholic Fatty Liver Disease
Grossmann, M., Wierman, M. E., Angus, P., & Handelsman, D. J. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00158 · Cited by 146
Vascular involvement of the liver in Turner's syndrome
Roulot, D., Degott, C., Chazouillères, O., Oberti, F., Calès, P., Carbonell, N., Benferhat, S., Bresson-Hadni, S., & Valla, D. (2004) · Hepatology · doi:10.1002/hep.20026 · Cited by 143
“(%) (Coarctation, bicuspidia, stenosis)] 6 (20) 5 (50)† 1 (6) Renal malformations [no.”
The epidemiology of sex chromosome abnormalities
Berglund, A., Stochholm, K., & Gravholt, C. H. (2020) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31805 · Cited by 143
“In a study of all females diagnosed with TS during 1960–1992 (n = 594) and the Danish female population (n = 2,594,036 females), the incidence of diseases suspected to occur with increased frequency in TS were compared using relative risk (RR) as the measure of association (Gravholt et al., 1998).”
BackgroundMethodResultInfluentialBlood pressure and Turner syndrome
Nathwani, Unwin, Brook, & Hindmarsh (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.00960.x · Cited by 139
Bakalov, V. K., Gutin, L. S., Cheng, C. M., Zhou, J., Sheth, P., Shah, K. R., Arepalli, S., Vanderhoof, V. H., Nelson, L. M., & Bondy, C. A. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.01.015 · Cited by 141
“Over the years several studies have described increased incidence of variety of autoimmune conditions besides HT, such as Type 1 diabetes [3,5,6], celiac disease [6], and ulcerative colitis [3].”
BackgroundResultInfluentialHRT for women with premature ovarian insufficiency: a comprehensive review
Webber, L., Anderson, R. A., Davies, M., Janse, F., & Vermeulen, N. (2017) · Human Reproduction Open · doi:10.1093/hropen/hox007 · Cited by 141
“Short-term studies of HRT in TS women have failed to show a favorable effect on lipid profile (Gravholt et al., 1998; Elsheikh et al., 2000), or on ambulatory arterial stiffness index (Mortensen et al.”
BackgroundImpaired insulin secretion in the Turner metabolic syndrome
Bakalov, V. K., Cooley, M. M., Quon, M. J., Luo, M. L., Yanovski, J. A., Nelson, L. M., Sullivan, G., & Bondy, C. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0122 · Cited by 137
“fold increase in insulin-dependent diabetes mellitus (defined by the use of insulin) and an approximately 4-fold increase in noninsulin-dependent diabetes mellitus in TS (3).”
BackgroundResultCarel, J., Écosse, E., Bastié-Sigeac, I., Cabrol, S., Tauber, M., Léger, J., Nicolino, M. P., Brauner, R., Chaussain, J., & Coste, J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1395 · Cited by 132
“Otological disorders are common in Turner’s syndrome, affecting up to 70% of patients, and lead to hearing impairment in up to 90% of adult patients (2, 26, 27).”
BackgroundIncreased fracture rates in Turner's syndrome: a nationwide questionnaire survey
Gravholt, C. H., Vestergaard, P., Hermann, A. P., Mosekilde, L., Brixen, K., & Christiansen, J. S. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01807.x · Cited by 130
Clinical practice in Turner syndrome
Gravholt, C. H. (2005) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0024 · Cited by 130
“In a study of all women in Denmark that compared all diagnosed females with TS with the background population of women, we calculated incidence rates for diseases that are suspected to occur with increased frequency in TS”
BackgroundA basic understanding of Turner syndrome: Incidence, complications, diagnosis, and treatment
Cui, X., Cui, Y., Shi, L., Luan, J. Y., Zhou, X., & Han, J. (2018) · Intractable & Rare Diseases Research · doi:10.5582/irdr.2017.01056 · Cited by 131
Chromosomal mosaicism mitigates stigmata and cardiovascular risk factors in Turner syndrome
El‐Mansoury, M., Barrenäs, M., Bryman, I., Hanson, C., Larsson, C., Wilhelmsen, L., & Landin‐Wilhelmsen, K. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02807.x · Cited by 122
Metabolic impact of sex chromosomes
Link, J. C., Chen, X., Arnold, A. P., & Reue, K. (2013) · Adipocyte · doi:10.4161/adip.23320 · Cited by 121
Congenital Cardiovascular Disease in Turner Syndrome
Bondy, C. A. (2008) · Congenital Heart Disease · doi:10.1111/j.1747-0803.2007.00163.x · Cited by 117
Hagman, A., Loft, A., Wennerholm, U.-B., Pinborg, A., Bergh, C., Aittomaki, K., Nygren, K.-G., Bente Romundstad, L., Hazekamp, J., & Soderstrom-Anttila, V. (2013) · Human Reproduction · doi:10.1093/humrep/det082 · Cited by 118
“Renal disorders are common in TS, and occur in 30–40% of the women, which is nine times higher than in the general population (Gravholt et al., 1998).”
BackgroundResultNabhan, Z. M., DiMeglio, L. A., Qi, R., Perkins, S. M., & Eugster, E. A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2123 · Cited by 119
Optimising management in Turner syndrome: from infancy to adult transfer
Donaldson, M. (2006) · Archives of Disease in Childhood · doi:10.1136/adc.2003.035907 · Cited by 119
Gravholt, C. H., Lauridsen, A. L., Brixen, K., Mosekilde, L., Heickendorff, L., & Christiansen, J. S. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.6.8598 · Cited by 119
“Recently, we observed that the increased risk of fractures in TS was present already in childhood and persisted throughout all age groups (9).”
BackgroundLong-term safety of recombinant human growth hormone in Turner syndrome
Bolar, K., Hoffman, A. R., Maneatis, T., & Lippe, B. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1723 · Cited by 116
“carbohydrate abnormality (18), the underlying mechanisms re-”
BackgroundJi, J., Zöller, B., Sundquist, J., & Sundquist, K. (2016) · International Journal of Cancer · doi:10.1002/ijc.30126 · Cited by 116
X-chromosome gene dosage and the risk of diabetes in Turner syndrome
Bakalov, V. K., Cheng, C., Zhou, J., & Bondy, C. A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0384 · Cited by 118
Hormone replacement therapy may improve hepatic function in women with Turner's syndrome
Elsheikh, M., Hodgson, H. J. F., Wass, J. A. H., & Conway, G. S. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01321.x · Cited by 109
Gravholt, C. H., Hjerrild, B., Mosekilde, L., Hansen, T. K., Rasmussen, L. M., Frystyk, J., Flyvbjerg, A., & Christiansen, J. S. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02267 · Cited by 112
“Glucose metabolism is altered in TS and type 2 diabetes is seen frequently ( 9 ); insulin resistance has been reported in some studies on children (10, 11), while studies on adults have pointed towards b-cell failure rather than insulin resistance as the primary defect in glucose homeostasis (5, 12, 13).”
BackgroundGonadoblastoma in Turner syndrome and Y‐chromosome‐derived material
Mazzanti, L., Cicognani, A., Baldazzi, L., Bergamaschi, R., Scarano, E., Strocchi, S., Nicoletti, A., Mencarelli, F., Pittalis, M. C., Forabosco, A., et al. (2005) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30569 · Cited by 110
“Three register studies have been carried out in Denmark [Naeraa et al., 1995; Hasle et al., 1996; Gravholt et al., 1998] and no cases of gonadoblastoma or related cancers and no cases of death after gonadoblastoma were reported.”
BackgroundBishop, N. J., Braillon, P. M., Burnham, J. M., Cimaz, R., Davies, J. H., Fewtrell, M. S., Högler, W., Kennedy, K., Mäkitie, O., Zulf Mughal, M., et al. (2008) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2007.12.004 · Cited by 109
Landin-Wilhelmsen, K., Bryman, I., & Wilhelmsen, L. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7818 · Cited by 113
Ostberg, J. E., Storry, C., Donald, A. E., Hosseinzadeh‐Attar, M. J., Halcox, J., & Conway, G. S. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02772.x · Cited by 106
Survival among people with Down syndrome: a nationwide population-based study in Denmark
Zhu, J. L., Hasle, H., Correa, A., Schendel, D., Friedman, J. M., Olsen, J., & Rasmussen, S. A. (2012) · Genetics in Medicine · doi:10.1038/gim.2012.93 · Cited by 106
Stroke in Women: Risk Factors and Clinical Biomarkers
Mirzaei, H. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26130 · Cited by 105
Management of Cardiovascular Risk Factors in Adults With Congenital Heart Disease
Lui, G. K., Fernandes, S. M., & McElhinney, D. B. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.001076 · Cited by 103
Gravholt, C. H., Svenstrup, B., Bennett, P., & Christiansen, J. S. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00720.x · Cited by 104
“…excess of sexual problems (Sylvent al., 1993), reduced bone mineral content, osteoporosis and an increased incidence of fractures (Brownet al., 1974; Stepanet al., 1989; Gravholt et al., 1998), conditions which perhaps could be alleviated or abolished by substitution with a low dose of androgens.”
BackgroundHögler, W., BRIODY, J. N., Moore, B., Garnett, S. P., Lu, P. W., & Cowell, C. T. C. T. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030799 · Cited by 102
Torres-Santiago, L., Mericq, V., Taboada, M., Unanue, N., Klein, K. O., Singh, R., Hossain, J., Santen, R. J., Ross, J. L., & Mauras, N. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4243 · Cited by 99
Wilton, P., Mattsson, A. F., & Darendelıler, F. (2010) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2010.02.028 · Cited by 98
Wilkin, T. J., & Murphy, M. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803317 · Cited by 97
Sex differences in lipid metabolism and metabolic disease risk
Sugiyama, M. G., & Agellon, L. B. (2012) · Biochemistry and Cell Biology · doi:10.1139/o11-067 · Cited by 98
“A large scale retrospective analysis of morbidity found that women with TS are at greater risk for the development of acquired metabolic syndromes, namely diabetes, atherosclerosis, ischemic heart disease, and hypertension (Gravholt et al. 1998).”
BackgroundLiver involvement in Turner syndrome
Roulot, D. M. (2012) · Liver International · doi:10.1111/liv.12007 · Cited by 95
“Accordingly, a five-fold increased risk of ‘cirrhosis’ was reported in Turner syndrome patients, compared to control patients (20).”
BackgroundOsteoporosis in Children and Adolescents
Baroncelli, G. I., Bertelloni, S., Sodini, F., & Saggese, G. (2005) · Pediatric Drugs · doi:10.2165/00148581-200507050-00003 · Cited by 94
“[78-81] However, patients with a mutation in the androgen receptor gene or having Bakalov et al.”
BackgroundNocturnal hypertension and impaired sympathovagal tone in Turner syndrome
Gravholt, C. H., Hansen, K. W., Erlandsen, M., Ebbehøj, E., & Christiansen, J. S. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000200509.17947.0f · Cited by 90
Self-citationMonosomy for the X-Chromosome Is Associated with an Atherogenic Lipid Profile
Van, P. L., Bakalov, V. K., & Bondy, C. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0503 · Cited by 89
Bechtold, S. M., Rauch, F., Noelle, V., Donhauser, S., Neu, C. M., Schöenau, E., & Schwarz, H. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8063 · Cited by 88
“creased by about 2-fold in TS patients (3).”
BackgroundLong-term outcomes in patients with Turner syndrome: a 68-year follow-up
Fuchs, M. M., Attenhofer Jost, C., Babovic‐Vuksanovic, D., Connolly, H. M., & Egbe, A. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.011501 · Cited by 88
Bone mineral density and fractures in Turner syndrome
Bakalov, V. K., Chen, M. L., Baron, J., Hanton, L., Reynolds, J. C., Stratakis, C. A., Axelrod, L., & Bondy, C. A. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00364-4 · Cited by 87
“A study based on Danish registry data reported an approximately twofold increased incidence of fractures in adults with Turner syndrome (25).”
BackgroundAutoimmunity and Turner's syndrome
Lleò, A., Moroni, L., Caliari, L., & Invernizzi, P. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.11.015 · Cited by 86
Hjerrild, B., Mortensen, K. H., Sørensen, K. E., Pedersen, E. M., Andersen, N. H., Lundorf, E., Hansen, K. W., Hørlyck, A., Hager, A., Christiansen, J. S., et al. (2010) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-12-12 · Cited by 85
“The high prevalence of congenital cardiovascular malformations [2,3] and hypertension also contributes adversely to the increased cardiovascular morbidity and mortality [4].”
BackgroundElsheikh, M., Bird, R., Casadei, B., Conway, G. S., & Wass, J. A. H. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.2.6384 · Cited by 86
“Type 2 diabetes mellitus occurs with an increased frequency in TS ( 5 , 40, 41), and this has been shown to adversely affect cardiovascular risk in females.”
BackgroundOstberg, J. E., Thomas, E. L., Hamilton, G., Hosseinzadeh‐Attar, M. J., Bell, J. D., & Conway, G. S. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1939 · Cited by 83
“Type II diabetes is four times more prevalent in TS than in the general population (1).”
BackgroundInfluentialProcréation et syndrome de Turner : quelles recommandations avant, pendant et après la grossesse ?
Fénichel, P., & Letur, H. (2008) · Gynécologie Obstétrique & Fertilité · doi:10.1016/j.gyobfe.2008.06.021 · Cited by 83
Autoimmune stigmata in Turner syndrome: When lacks an X chromosome
Larizza, D., Calcaterra, V., & Martinetti, M. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.03.002 · Cited by 81
“Only one study [64] showed an 11-fold increase in the frequency of type 1 DM in their study population and this result, as reported by Elsheikh [56], might be due to the misclassification of insulin requiring type 2 DM.”
ResultDeterminants of medical care for young women with Turner syndrome
Devernay, M., Ecosse, E., Coste, J., & Carel, J.-C. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0495 · Cited by 79
“5–25 269 (47) 25 127 (22) Missing data 51 (9) Karyotype, n (%) 45,X 299 (53) Other 269 (48) Disease components of TS, n (%) Otological involvement 149 (26) Cardiac involvement 71 (12) Diabetes 12 (2) Thyroid disease 89 (16) Liver disease 22 (4) Lipid abnormalities 15 (3) Hypertension 26 (5) Number of disease component…”
BackgroundReproductive Issues in Women with Turner Syndrome
Folsom, L. J., & Fuqua, J. S. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.07.004 · Cited by 79
“reported 26 women with Turner syndrome who underwent oral glucose tolerance testing prior to and after receiving six months of sex hormone replacement therapy (40).”
The influence of renal and cardiovascular abnormalities on blood pressure in Turner syndrome
Nathwani, Unwin, Brook, & Hindmarsh (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.00961.x · Cited by 80
“This and other studies have demonstrated that patients with TS have increased morbidity and mortality (Gravholt et al., 1998), and that cardiovascular diseases, congenital or acquired, were the single highest cause of death.”
BackgroundResultChoosing an oestrogen replacement therapy in young adult women with Turner syndrome
Guttmann, H., Weiner, Z., Nikolski, E., Ish‐Shalom, S., Itskovitz‐Eldor, J., Aviram, M., Reisner, S., & Hochberg, Z. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01181.x · Cited by 78
Hypertension, Obesity, and Coronary Artery Disease in the Survivors of Congenital Heart Disease
Roche, S. L., & Silversides, C. K. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2013.03.021 · Cited by 78
“They are prone to early diabetes, hypertension, and abnormal lipid profiles(78,79) and in 1 populationbased study, these women’s risk of developing ischemic heart disease was estimated at twice that of the general population.(78) It is likely that any increased risk of CAD seen in young women with Turner syndrome is m…”
BackgroundKhastgir, G., Studd, J. W. W., Fox, S. W., Jones, J., Alaghband‐Zadeh, J., & Chow, J. W. M. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.5.925 · Cited by 72
“6), respectively.((21)) An alternative explanation is that the physiological levels of serum estradiol that may be required to optimize bone formation are not achieved with standard doses of HRT.”
BackgroundWooten, N., Bakalov, V. K., Hill, S. C., & Bondy, C. A. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2266 · Cited by 74
“Diabetes mellitus is increased among women with Turner syndrome (TS) (1, 2).”
BackgroundKoulouri, O., Ostberg, J., & Conway, G. S. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03203.x · Cited by 71
Structural and functional abnormalities of large arteries in the Turner syndrome
Baguet, J.-P., Douchin, S., Pierre, H., Rossignol, A.-M., Bost, M., & Mallion, J.-M. (2005) · Heart · doi:10.1136/hrt.2004.048371 · Cited by 72
Reduced cortical bone density with normal trabecular bone density in girls with Turner syndrome
Holroyd, C. R., Davies, J. H., Taylor, P., Jameson, K., Rivett, C., Cooper, C. C., & Dennison, E. M. (2010) · Osteoporosis International · doi:10.1007/s00198-010-1170-0 · Cited by 72
“Several authors have documented an association between TS and an increased risk of fracture in both childhood [6] and adulthood [7, 8], although prospective studies on fracture incidence are lacking.”
BackgroundSas, T., Keizer‐Schrama, S. M. P. F. D. M., Stijnen, T., Aanstoot, H., & Drop, S. L. S. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.2.6334 · Cited by 78
“In addition, in adults with TS who had not received GH treatment in childhood, glucose intolerance and noninsulinand insulin-dependent diabetes mellitus are more common than in healthy women ( 13 , 14).”
BackgroundFracture risk and bone mineral density in Turner syndrome
Bakalov, V. K., & Bondy, C. A. (2008) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9076-2 · Cited by 70
“Gravholt et al., using data from the Danish Cytogenetic Central Register and the Danish National Registry, found that women with TS had two times higher risk of a fracture-related hospital admission compared to 46,XX women (10 year relative risk 2.16, 95% confidence interval 1.5–3.0) [ 4 ].”
MethodInfluential
Metadata
- Authors
- Gravholt, C. H., Juul, S., Naeraa, R. W., & Hansen, J.
- Affiliations
- Aarhus University (DK)
- Aarhus University Hospital (DK)
- Corresponding author
- Gravholt, Claus Højbjerg
- Venue
- Journal of Clinical Epidemiology
- Publisher
- Elsevier BV
- Published
- 1998-02
- Volume
- 51
- Issue
- 2
- Pages
- 147-158
- ISSN
- 0895-4356 (ISSN-L)
- OpenAlex
- W2037733089
- Cited by
- 548
- References
- 98
- Citations by year
- 2026: 8 · 2025: 15 · 2024: 18 · 2023: 23 · 2022: 15 · 2021: 19 · 2020: 20 · 2019: 27 · 2018: 26 · 2017: 24 · 2016: 18 · 2015: 26 · 2014: 16 · 2013: 22 · 2012: 22
- FWCI
- 7.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
- Keywords
- Turner syndrome, morbidity, disease incidence, osteoporotic fractures, diabetes mellitus, type 2 diabetes, type 1 diabetes, ischemic heart disease, hypertension, stroke, cancer risk, metabolic syndrome, dyslipidemia, hyperinsulinemia, hyperuricemia, adult women
- MeSH terms
- Adolescent, Adult, Aged, Child, Child, Preschool, Denmark, Female, Humans, Infant, Karyotyping, Middle Aged, Morbidity, Registries, Risk Factors, Turner Syndrome, Comorbidity, Incidence, Age Distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review